METTLER TOLEDO INTERNATIONAL INC/ MTD

Technology SIC 3826 - Laboratory Analytical Instruments NAICS Manufacturing › Computer and Electronic Product Manufacturing › Navigational, Measuring, Electromedical, and Control Instruments Manufacturing › Analytical Laboratory Instrument Manufacturing derived NYSE

We are a leading global supplier of precision instruments and services. We have strong leadership positions in all of our businesses and believe we hold global number-one market positions in most of them. We are recognized as an innovation leader and our solutions are critical in key research and development, quality control, and manufacturing processes for customers in a wide range of industries including life sciences, food, and chemicals. Our sales and service network is one of the most extensive in the industry. Our products are sold in more than 140 countries and we have a direct presence in approximately 40 countries. With proven growth strategies and a focus on execution, we have achieved a long-term track record of strong financial performance.

Last close 1,669.62 2026-10-26
Market cap $33.45B 2026-06-30 share count
52-week range 1,023.05 - 1,713.38

Valuation FY2025 figures against the last close

P/S8.3x
P/E39.7x
P/FCF39.4x
EV/EBITDA—
Dividend yield—
Diluted EPS42.05

Where the revenue comes from as reported in the latest 10-K

Revenue by geography

  • United States
  • China
  • Other Europe
  • Rest Of World
  • Other Americas
  • Germany
  • France
  • Switzerland
  • United Kingdom
Revenue by geography, 9 categories over 3 years. The same figures are in the table below. FY2025 United States, FY2025: 1.4B (35.3%) 35% United States China, FY2025: 626.8M (15.6%) 16% China Other Europe, FY2025: 569.3M (14.1%) 14% Other Europe Rest Of World, FY2025: 559.2M (13.9%) 14% Rest Of World Other Americas, FY2025: 258.7M (6.4%) 6% Germany, FY2025: 242.6M (6.0%) 6% Germany France, FY2025: 164.6M (4.1%) 4% Switzerland, FY2025: 95.4M (2.4%) United Kingdom, FY2025: 89.1M (2.2%) FY2024 United States, FY2024: 1.4B (35.1%) 35% China, FY2024: 621.8M (16.1%) 16% Other Europe, FY2024: 533.2M (13.8%) 14% Rest Of World, FY2024: 543.9M (14.0%) 14% Other Americas, FY2024: 247.5M (6.4%) 6% Germany, FY2024: 236.3M (6.1%) 6% France, FY2024: 152.8M (3.9%) 4% Switzerland, FY2024: 93.6M (2.4%) United Kingdom, FY2024: 84.4M (2.2%) FY2023 United States, FY2023: 1.3B (35.5%) 36% China, FY2023: 707.6M (18.7%) 19% Other Europe, FY2023: 483.7M (12.8%) 13% Rest Of World, FY2023: 497M (13.1%) 13% Other Americas, FY2023: 221.7M (5.9%) 6% Germany, FY2023: 221.5M (5.8%) 6% France, FY2023: 139.3M (3.7%) 4% Switzerland, FY2023: 91.6M (2.4%) United Kingdom, FY2023: 79.5M (2.1%)
Region FY2025FY2024FY2023
United States $1.42B $1.36B $1.35B
China $626.8M $621.8M $707.6M
Other Europe $569.3M $533.2M $483.7M
Rest Of World $559.2M $543.9M $497.0M
Other Americas $258.7M $247.5M $221.7M
Germany $242.6M $236.3M $221.5M
France $164.6M $152.8M $139.3M
Switzerland $95.4M $93.6M $91.6M
United Kingdom $89.1M $84.4M $79.5M

As the company reported it, from the “Segment Reporting Sales and PPE by Destination (Details)” note of its latest 10-K. Every figure here has been checked against the total revenue the same filing reported. Regions are the filer's own and are not mapped onto a standard list — one company's “Americas” and another's “United States” are different areas, and making them look comparable would mean making at least one of them wrong. Slices under 1% are folded into “Other”.

Annual financial statements

Income statement

Fiscal year FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Revenue $4.03B$3.87B$3.79B$3.92B$3.72B$3.09B$3.01B$2.94B$2.73B$2.51B
Cost of revenue ————————$317.9M$304.9M
Gross profit $2.39B$2.33B$2.24B$2.31B$2.17B$1.80B$1.74B$1.68B$1.58B$1.44B
R&D $199.4M$189.4M$185.3M$177.1M$169.8M$140.1M$143.9M$141.1M$128.3M$119.2M
SG&A $998.3M$936.3M$904.1M$938.5M$944.0M$820.2M$819.2M$812.8M$794.9M$745.4M
Interest expense $68.5M$74.6M$77.4M$55.4M$43.2M$38.6M$37.4M$34.5M$32.8M$28.0M
Pre-tax income $1.05B$1.04B$973.7M$1.07B$949.4M$748.7M$681.4M$651.9M$574.2M$504.2M
Income tax $179.7M$174.1M$184.9M$198.1M$180.4M$146.0M$120.3M$139.2M$198.2M$119.8M
Net income $869.2M$863.1M$788.8M$872.5M$769.0M$602.7M$561.1M$512.6M$376.0M$384.4M
EPS, basic 42.1740.6736.1038.7933.2525.2422.8420.3314.6214.49
EPS, diluted 42.0540.4835.9038.4132.7824.9122.4719.8814.2414.22
Shares, diluted (wtd. avg.) 20.7M21.3M22.0M22.7M23.5M24.2M25.0M25.8M26.4M27.0M

Balance sheet

Fiscal year FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash and equivalents $66.9M$59.4M$69.8M$96.0M$98.6M$94.3M$207.8M$178.1M$148.7M$158.7M
Receivables $778.2M$687.1M$663.9M$709.3M$647.3M$593.8M$566.3M$535.5M——
Inventory $387.2M$342.3M$385.9M$441.7M$414.5M$297.6M$274.3M$268.8M——
Total current assets $1.36B$1.19B$1.23B$1.38B$1.27B$1.06B$1.11B$1.05B——
Property, plant and equipment $845.6M$770.3M$803.4M$778.6M$799.4M$798.9M$748.7M$717.5M——
Goodwill $739.2M$668.9M$670.1M$660.2M$648.6M$550.3M$536.0M$534.8M$539.8M—
Other intangibles $278.9M$257.1M$285.4M$306.1M$307.4M$196.8M$206.2M$217.3M——
Total assets $3.71B$3.24B$3.36B$3.49B$3.33B$2.81B$2.79B$2.62B$2.55B—
Accounts payable $266.6M$215.8M$210.4M$252.5M$272.9M$175.8M$185.6M$196.6M——
Short-term debt $63.9M$182.6M$192.2M$106.1M$101.1M$50.3M$55.9M$49.7M——
Total current liabilities $1.20B$1.17B$1.18B$1.15B$1.15B$840.3M$754.5M$734.4M——
Long-term debt $2.09B$1.83B$1.89B$1.91B$1.58B$1.28B$1.24B$985.0M——
Total liabilities $3.74B$3.37B$3.51B$3.47B$3.16B$2.53B$2.37B$2.03B——
Retained earnings $9.24B$8.37B$7.51B$6.73B$5.86B$5.10B$4.50B$3.94B——
Total equity -$23.6M-$126.9M-$149.9M$24.8M$171.4M$282.7M$420.8M$590.1M$547.3M$434.9M

Cash flow

Fiscal year FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Operating cash flow $955.8M$968.3M$965.9M$859.1M$908.8M$724.7M$603.5M$565.0M$516.3M$460.8M
Depreciation and amortisation $51.1M$50.4M$49.0M$46.8M$45.0M$42.0M$39.0M$37.2M$33.5M$32.7M
Stock-based compensation $22.5M$20.0M$17.9M$19.7M$19.6M$18.7M$18.3M$17.6M$16.6M$15.3M
Capital expenditure $107.1M$103.9M$105.3M$121.2M$107.6M$92.5M$97.3M$142.7M$127.4M$124.0M
Investing cash flow -$193.9M-$119.5M-$131.7M-$139.4M-$314.1M-$100.4M-$99.1M-$138.9M-$217.3M-$231.5M
Financing cash flow -$755.2M-$856.0M-$859.6M-$716.0M-$590.5M-$743.9M-$477.4M-$388.0M-$319.5M-$163.6M
Buybacks $800.0M$850.0M$900.0M$1.10B$1,000.0M$775.0M$775.0M$475.0M$400.0M$500.0M

Figures as tagged in each year's own filing, in US dollars. A year restated by a later filing shows the restated figure. Capital expenditure, dividends and buybacks are cash out, shown positive. A line the filer does not report is not listed. Latest from accession 0001037646-26-000011.

Plot the figures US dollars

Income statement Revenue Cost of revenue Gross profit R&D SG&A Total operating expenses Operating income Interest expense Pre-tax income Income tax Net income EPS, basic EPS, diluted Shares, diluted (wtd. avg.)
Balance sheet Cash and equivalents Short-term investments Receivables Inventory Total current assets Property, plant and equipment Goodwill Other intangibles Total assets Accounts payable Short-term debt Total current liabilities Long-term debt Total liabilities Retained earnings Total equity
Cash flow Operating cash flow Depreciation and amortisation Stock-based compensation Capital expenditure Investing cash flow Financing cash flow Dividends paid Buybacks
  • Revenue
  • Gross profit
  • Net income
Revenue, Gross profit, Net income by fiscal year, in US dollars The same figures are in the table below this chart. 0 2B 4B 6B Revenue, FY2016: 2.5B Gross profit, FY2016: 1.4B Net income, FY2016: 384.4M Revenue, FY2017: 2.7B Gross profit, FY2017: 1.6B Net income, FY2017: 376M Revenue, FY2018: 2.9B Gross profit, FY2018: 1.7B Net income, FY2018: 512.6M Revenue, FY2019: 3B Gross profit, FY2019: 1.7B Net income, FY2019: 561.1M Revenue, FY2020: 3.1B Gross profit, FY2020: 1.8B Net income, FY2020: 602.7M Revenue, FY2021: 3.7B Gross profit, FY2021: 2.2B Net income, FY2021: 769M Revenue, FY2022: 3.9B Gross profit, FY2022: 2.3B Net income, FY2022: 872.5M Revenue, FY2023: 3.8B Gross profit, FY2023: 2.2B Net income, FY2023: 788.8M Revenue, FY2024: 3.9B Gross profit, FY2024: 2.3B Net income, FY2024: 863.1M Revenue, FY2025: 4B Gross profit, FY2025: 2.4B Net income, FY2025: 869.2M FY2016 FY2017 FY2018 FY2019 FY2020 FY2021 FY2022 FY2023 FY2024 FY2025
Fiscal year FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Revenue $2.51B $2.73B $2.94B $3.01B $3.09B $3.72B $3.92B $3.79B $3.87B $4.03B
Gross profit $1.44B $1.58B $1.68B $1.74B $1.80B $2.17B $2.31B $2.24B $2.33B $2.39B
Net income $384.4M $376.0M $512.6M $561.1M $602.7M $769.0M $872.5M $788.8M $863.1M $869.2M

Recent filings and events

  • Officer or director change Someone at the top arrived or left. The item covers everything from a board retirement to a chief executive being removed, and only the filing itself says which. Item 5.02
  • Regulation FD disclosure Something the company told the market and had to tell everyone at once - usually a slide deck or a press release. Item 7.01
  • Results announced The quarterly or annual earnings release. Arrives four times a year from almost every company here. Item 2.02
  • Officer or director change Item 5.02
  • Shareholder vote The results of the annual meeting or a special vote. Item 5.07
  • Results announced Item 2.02
  • Annual report filed A new 10-K. The figures and the business description on this site come from it. Form 10-K
  • Results announced Item 2.02
  • Officer or director change Item 5.02
  • Regulation FD disclosure Item 7.01
  • Results announced Item 2.02
  • Officer or director change Item 5.02

Item numbers are Form 8-K's own, and a filing date is up to four business days after the thing it reports. The same feed across the whole market.

Others in SIC 3826

TickerCompanyMarket capP/ERevenue growth
A AGILENT TECHNOLOGIES, INC. $49.61B 38.5x 6.7%
WAT WATERS CORP /DE/ $44.80B 42.4x 7.0%
ILMN ILLUMINA, INC. $40.93B 49.7x -0.7%
RVTY REVVITY, INC. $17.90B 77.5x 3.7%
AVTR Avantor, Inc. $11.80B — -3.4%
BIO BIO-RAD LABORATORIES, INC. $9.96B 13.4x 0.7%
TXG 10x Genomics, Inc. $9.48B — 5.2%
BRKR BRUKER CORP $8.83B — 2.1%